Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers
Conditions
- Adenocarcinoma of the Pancreas
- Stage III Pancreatic Cancer
- Stage IV Pancreatic Cancer
- Unspecified Adult Solid Tumor, Protocol Specific
Interventions
- DRUG: dovitinib lactate
- DRUG: gemcitabine hydrochloride
- DRUG: capecitabine
- OTHER: laboratory biomarker analysis
- OTHER: enzyme-linked immunosorbent assay
- OTHER: pharmacological study
Sponsor
Roswell Park Cancer Institute
Collaborators